Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 11/20 | 0.67 |
| ▸ | MAOA | P21397 | 2/20 | 0.67 |
| ▸ | MAOB | P27338 | 2/20 | 0.67 |
| ▸ | APP | P05067 | 2/20 | 0.52 |
| ▸ | NQO2 | P16083 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.41 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.41 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.40 |
| ▸ | KDM1A | O60341 | 3/20 | 0.39 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10950803 | 1.00 | CYP19A1 (0.67) | CYP19A1MAOAMAOBAPPNQO2 | |
| SCHEMBL10950815 | 1.00 | CYP19A1 (0.67) | CYP19A1MAOAMAOBAPPNQO2 | |
| SCHEMBL28604671 | 0.96 | CYP19A1 (0.75) | CYP19A1MAOAMAOBAPPNQO2 | |
| SCHEMBL26867256 | 0.90 | CYP19A1 (0.55) | CYP19A1MAOAMAOBAPPNQO2 | |
| SCHEMBL5277570 | 0.85 | CYP19A1 (0.59) | CYP19A1MAOAMAOBAPPNQO2 | |
| SCHEMBL5277575 | 0.85 | CYP19A1 (0.59) | CYP19A1MAOAMAOBAPPNQO2 | |
| SCHEMBL4288335 | 0.83 | NFE2L2 (0.54) | CYP19A1MAOAMAOBMEN1KMT2A | |
| SCHEMBL30129708 | 0.80 | NFE2L2 (0.56) | CYP19A1MAOAMAOBMEN1KMT2A | |
| SCHEMBL4304905 | 0.80 | NFE2L2 (0.56) | CYP19A1MAOAMAOBMEN1KMT2A | |
| SCHEMBL4304901 | 0.80 | NFE2L2 (0.56) | CYP19A1MAOAMAOBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112939813-B | 9-aryl-10-aryloxy anthracene derivative, preparation method thereof and application thereof as luminescent material | 江西师范大学 | 2022-06-17 | — | — | CN | disclosed |
| CN-112939813-A | 9-aryl-10-aryloxy anthracene derivative, preparation method thereof and application thereof as luminescent material | 江西师范大学 | 2021-06-11 | — | — | CN | disclosed |
| US-20090035576-A1 | Nanoparticles for two-photon activated photodynamic therapy and imaging | HEALTH RESEARCH, INC. | 2009-02-05 | — | — | US | disclosed |
| US-20080233051-A1 | Nanoparticles for two-photon activated photodynamic therapy and imaging | HEALTH RESEARCH, INC. | 2008-09-25 | — | — | US | disclosed |
| WO-2008030624-A2 | NANOPARTICLES FOR TWO-PHOTON ACTIVATED PHOTODYNAMIC THERAPY AND IMAGING | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2008-03-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080233051-A1 | Nanoparticles for two-photon activated photodynamic therapy and imaging | ORMDL3, PPOX, ORC3 | CYP19A1 4218/4885MAOA 3527/4885MAOB 3848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.